+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three & Five Injections), By End Use (Hospitals & Orthopedic Clinics/ASCs), By Region (North America, Europe, APAC, LATAM & MEA), And Segment Forecasts, 2025 - 2033- Product Image
Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three & Five Injections), By End Use (Hospitals & Orthopedic Clinics/ASCs), By Region (North America, Europe, APAC, LATAM & MEA), And Segment Forecasts, 2025 - 2033- Product Image
New

Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three & Five Injections), By End Use (Hospitals & Orthopedic Clinics/ASCs), By Region (North America, Europe, APAC, LATAM & MEA), And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 118 Pages
  • July 2025
  • Region: Global
  • Grand View Research
  • ID: 5440498
Description Jump to:
The global viscosupplementation market size was estimated at USD 5.30 billion in 2024 and is projected to reach USD 9.39 billion by 2033, growing at a CAGR of 6.21% from 2025 to 2033. Viscosupplementation aims to alleviate joint pain and enhance the functional state of the knee.

The growing incidence of osteoarthritis plays a significant role in driving the demand for viscosupplementation. Osteoarthritis, a chronic degenerative joint disease, is the primary cause of enduring disability. It typically emerges after the age of 30 and can progress to a disabling condition within a decade of diagnosis. In March 2025, an article published in Scientific Reports analyzed osteoarthritis data from the Global Burden of Disease Study 2021. The study reported a sharp rise in global OA incidence from 20.9 million cases in 1990 to 46.6 million in 2021, with a notable increase in years lived with disability. It also highlighted growing health inequalities, with a higher burden seen among women, in high SDI countries, and regions like Asia.

The rising incidence of joint disorders is a key driver of the viscosupplementation market. Degenerative conditions are becoming more common due to aging populations and sedentary lifestyles. This is leading to greater demand for non-surgical treatment approaches that provide symptom relief. Viscosupplementation addresses this by improving joint lubrication and mobility. Healthcare systems are recognizing the cost-effectiveness of delaying surgical intervention. In November 2024, an article in Osteoarthritis and Cartilage highlighted that osteoarthritis affected 7.6% of the global population in 2020, with prevalence increasing by 132.2% over the past 30 years. Moreover, it is noted that early-onset OA cases, occurring before age 55, accounted for over half of new diagnoses and 26.1% of total YLDs.

Preference for minimally invasive treatment options is contributing to market expansion. Patients and providers are increasingly opting for procedures that offer reduced recovery time and fewer complications. Viscosupplementation aligns with these needs, supporting its adoption in routine clinical practice. Ongoing developments in formulation are also influencing uptake. Single and multiple-injection regimens are now available to accommodate different patient profiles. In April 2024, a study published in Cureus analyzed arthritis trends among U.S. adults using BRFSS data from 2019 to 2022. The findings underscored rising prevalence and disparities by demographics and health status. These insights support growing adoption of minimally invasive surgeries (MIS) for arthritis, aimed at reducing pain, complications, and recovery time.

Growing awareness among healthcare providers and structured reimbursement policies are further supporting market growth. Continued clinical validation has led to broader acceptance of viscosupplementation in standard care protocols. This is encouraging its use at earlier stages of joint degeneration. Market players are responding with expanded product offerings to meet rising clinical demand. Regional regulatory support has facilitated product availability across key markets. In January 2024, Seikagaku Corporation announced collaborations with Anika Therapeutics and two other manufacturers to enhance multi-injection viscosupplementation products using novel cross-linked hyaluronic acid technologies.

Global Viscosupplementation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global viscosupplementation market report based on product, end use, and region:

Product Outlook (Revenue in USD Billion, 2021 - 2033)

  • Single Injection
  • Three Injection
  • Five Injection

End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospitals
  • Orthopedic Clinics/ASCs

Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Viscosupplementation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of osteoarthritis among aging populations
3.2.1.2. Rising demand for non-surgical pain management options in orthopedics
3.2.1.3. Advancements in hyaluronic acid formulations improving product efficacy
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatment limiting access in low- and middle-income countries
3.2.2.2. Limited long-term effectiveness leading to physician skepticism and guideline restrictions
3.3. Viscosupplementation: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
Chapter 4. Viscosupplementation Market Segment Analysis, By Product, 2021 - 2033 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global viscosupplementation market, by product, 2021 to 2033
4.5. Single injection
4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. Three injection
4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.7. Five injection
4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Viscosupplementation Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)
5.1. Definition and Scope
5.2. Segment Dashboard
5.3. Global viscosupplementation market, by End Use, 2021 to 2033
5.4. Hospitals
5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Orthopedic Clinic/ASCs
5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Viscosupplementation Market Segment Analysis, By Region, 2021 - 2033 (USD Million)
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Viscosupplementation Market Share by Region, 2024 & 2033:
6.5. North America
6.5.1. North America viscosupplementation market, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Scenario
6.5.2.4. U.S. viscosupplementation market, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Scenario
6.5.3.4. Canada viscosupplementation market, 2021 - 2033 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Scenario
6.5.4.4. Mexico viscosupplementation market, 2021 - 2033 (USD Million)
6.6. Europe
6.6.1. Europe viscosupplementation market, 2021 - 2033 (USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Scenario
6.6.2.4. UK viscosupplementation market, 2021 - 2033 (USD Million)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Scenario
6.6.3.4. Germany viscosupplementation market, 2021 - 2033 (USD Million)
6.6.4. France
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Scenario
6.6.4.4. France viscosupplementation market, 2021 - 2033 (USD Million)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Scenario
6.6.5.4. Italy viscosupplementation market, 2021 - 2033 (USD Million)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Scenario
6.6.6.4. Spain viscosupplementation market, 2021 - 2033 (USD Million)
6.6.7. Norway
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Scenario
6.6.7.4. Norway viscosupplementation market, 2021 - 2033 (USD Million)
6.6.8. Sweden
6.6.8.1. Key Country Dynamics
6.6.8.2. Regulatory Framework
6.6.8.3. Competitive Scenario
6.6.8.4. Sweden viscosupplementation market, 2021 - 2033 (USD Million)
6.6.9. Denmark
6.6.9.1. Key Country Dynamics
6.6.9.2. Regulatory Framework
6.6.9.3. Competitive Scenario
6.6.9.4. Denmark viscosupplementation market, 2021 - 2033 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Framework
6.7.1.3. Competitive Scenario
6.7.1.4. Japan viscosupplementation market, 2021 - 2033 (USD Million)
6.7.2. China
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Scenario
6.7.2.4. China viscosupplementation market, 2021 - 2033 (USD Million)
6.7.3. India
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Scenario
6.7.3.4. India viscosupplementation market, 2021 - 2033 (USD Million)
6.7.4. Australia
6.7.4.1. Key Country Dynamics
6.7.4.2. Regulatory Framework
6.7.4.3. Competitive Scenario
6.7.4.4. Australia viscosupplementation market, 2021 - 2033 (USD Million)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Regulatory Framework
6.7.5.3. Competitive Scenario
6.7.5.4. South Korea viscosupplementation market, 2021 - 2033 (USD Million)
6.7.6. Thailand
6.7.6.1. Key Country Dynamics
6.7.6.2. Regulatory Framework
6.7.6.3. Competitive Scenario
6.7.6.4. Thailand viscosupplementation market, 2021 - 2033 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Framework
6.8.1.3. Competitive Scenario
6.8.1.4. Brazil viscosupplementation market, 2021 - 2033 (USD Million)
6.8.2. Argentina
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Scenario
6.8.2.4. Argentina viscosupplementation market, 2021 - 2033 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key Country Dynamics
6.9.1.2. Regulatory Framework
6.9.1.3. Competitive Scenario
6.9.1.4. South Africa viscosupplementation market, 2021 - 2033 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key Country Dynamics
6.9.2.2. Regulatory Framework
6.9.2.3. Competitive Scenario
6.9.2.4. Saudi Arabia viscosupplementation market, 2021 - 2033 (USD Million)
6.9.3. UAE
6.9.3.1. Key Country Dynamics
6.9.3.2. Regulatory Framework
6.9.3.3. Competitive Scenario
6.9.3.4. UAE viscosupplementation market, 2021 - 2033 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key Country Dynamics
6.9.4.2. Regulatory Framework
6.9.4.3. Competitive Scenario
6.9.4.4. Kuwait viscosupplementation market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.4. Heatmap Analysis, 2024
7.5. Company Profile
7.5.1. DePuy Synthes
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Fidia Farmaceutici S.p.A
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Sanofi
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Anika Therapeutics, Inc.
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic initiatives
7.5.5. SEIKAGAKU CORPORATION
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Zimmer Biomet
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Smith & Nephew PLC
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Ferring Pharmaceutical B.V.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Lifecore Biomedical, LLC (Landec)
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. LG Life Sciences Ltd.
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic initiatives
7.5.11. F. Hoffmann-La Roche Ltd.
7.5.11.1. Company Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 4 North America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 5 U.S. Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 6 U.S. Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 7 Canada Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 8 Canada Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 9 Mexico Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 10 Mexico Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 11 Europe Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 12 Europe Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 13 UK Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 14 UK Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 15 Germany Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 16 Germany Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 17 France Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 18 France Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 19 Italy Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 20 Italy Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 21 Spain Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 22 Spain Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 23 Sweden Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 24 Sweden Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 25 Denmark Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 26 Denmark Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 27 Norway Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 28 Norway Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 29 Asia Pacific Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 30 Asia Pacific Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 31 Japan Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 32 Japan Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 33 China Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 34 China Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 35 India Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 36 India Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 37 Australia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 38 Australia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 39 South Korea Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 40 South Korea Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 41 Thailand Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 42 Thailand Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 43 Latin America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 44 Latin America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 45 Brazil Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 46 Brazil Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 47 Argentina Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 48 Argentina Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 49 MEA Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 50 MEA Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 51 South Africa Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 52 South Africa Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 53 Saudi Arabia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 54 Saudi Arabia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 55 UAE Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 56 UAE Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 57 Kuwait Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 58 Kuwait Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Viscosupplementation market: outlook
Fig. 8 Viscosupplementation competitive insights
Fig. 9 Ancillary market outlook
Fig. 10 Viscosupplementation market driver impact
Fig. 11 Viscosupplementation market restraint impact
Fig. 12 Porter’s Analysis
Fig. 13 PESTLE Analysis
Fig. 14 Viscosupplementation market: Product movement analysis
Fig. 15 Viscosupplementation market: Product outlook and key takeaways
Fig. 16 Single injection market estimates and forecast, 2021 - 2033
Fig. 17 Five injection market estimates and forecast, 2021 - 2033
Fig. 18 Toe intramedullary implants market estimates and forecast, 2021 - 2033
Fig. 19 Three injection market estimates and forecast, 2021 - 2033
Fig. 20 Scaphoid bone implants market estimates and forecast, 2021 - 2033
Fig. 21 Viscosupplementation market: End Use movement analysis
Fig. 22 Viscosupplementation market: End Use outlook and key takeaways
Fig. 23 Orthopedic Clinic/ASCs market estimates and forecasts, 2021 - 2033
Fig. 24 Hospitals market estimates and forecasts,2021 - 2033
Fig. 25 Global viscosupplementation market: Regional movement analysis
Fig. 26 Global viscosupplementation market: Regional outlook and key takeaways
Fig. 27 North America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Key country dynamics
Fig. 29 U.S. viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Key country dynamics
Fig. 31 Canada viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 Mexico viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Europe viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 UK viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Germany viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 Spain viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 France viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 Italy viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Norway viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Denmark viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Sweden viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Asia Pacific viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Japan viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 China viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 India viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Australia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 South Korea viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Thailand viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Latin America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Brazil viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Argentina viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 MEA viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 South Africa viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Saudi Arabia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 UAE viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Kuwait viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Key company categorization
Fig. 79 Heat map analysis, 2024

Companies Mentioned

  • DePuy Synthes
  • Fidia Farmaceutici S.p.A
  • Sanofi
  • Smith & Nephew PLC
  • Anika Therapeutics, Inc.
  • Seikagaku Corp.
  • Zimmer Biomet
  • Ferring Pharmaceuticals B.V.
  • Lifecore Biomedical
  • LG Life Sciences Ltd.
  • F.Hoffmann-La Roche Ltd.

Table Information

Report AttributeDetails
No. of Pages118
PublishedJuly 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 5.3 Billion
Forecasted Market Value ( USD ) by 2033 $ 9.39 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Viscosupplementation Market 2025-2033 - Product Image

Viscosupplementation Market 2025-2033

  • Report
  • 143 Pages
  • Global
From
Viscosupplementation Market, Global Forecast Report by by Product, By Application, by End User, Regions and Company Analysis 2025-2033 - Product Image

Viscosupplementation Market, Global Forecast Report by by Product, By Application, by End User, Regions and Company Analysis 2025-2033

  • Report
  • 200 Pages
  • Global
From
Viscosupplementation Market Report 2025 - Product Image

Viscosupplementation Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Viscosupplementation Injection Market by Product Type (Cross Linked Hyaluronic Acid, Non Cross Linked Hyaluronic Acid), Application Site (Hip, Knee, Shoulder), End User, Distribution Channel, Price Tier, Patient Age Group - Global Forecast 2025-2030 - Product Image

Viscosupplementation Injection Market by Product Type (Cross Linked Hyaluronic Acid, Non Cross Linked Hyaluronic Acid), Application Site (Hip, Knee, Shoulder), End User, Distribution Channel, Price Tier, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.